title: Follow-up on long-term antiretroviral therapy for cats infected with feline immunodeficiency virus.
abstract: OBJECTIVE
  Feline immunodeficiency virus (FIV) is a lentivirus that induces AIDS-like disease in cats. Some of the antiretroviral drugs available to treat patients with HIV type 1 are used to treat FIV-infected cats; however, antiretroviral therapy (ART) is not used in cats as a long-term treatment. In this study, the effects of long-term ART were evaluated in domestic cats treated initially with the nucleoside transcriptase reverse inhibitor (NTRI) zidovudine (AZT) over a period ranging from 5-6 years, followed by a regimen of the NTRI lamivudine (3TC) plus AZT over 3 years.
  
  
  METHODS
  Viral load, sequencing of pol (reverse transcriptase [RT]) region and CD4:CD8 lymphocyte ratio were evaluated during and after treatment. Untreated cats were evaluated as a control group.
  
  
  RESULTS
  CD4:CD8 ratios were lower, and uncharacterized resistance mutations were found in the RT region in the group of treated cats. A slight increase in viral load was observed in some cats after discontinuing treatment.
  
  
  CONCLUSIONS
  The data strongly suggest that treated cats were resistant to therapy, and uncharacterized resistance mutations in the RT gene of FIV were selected for by AZT. Few studies have been conducted to evaluate the effect of long-term antiretroviral therapy in cats. To date, resistance mutations have not been described in vivo.
authors: Laboratory of Molecular Virology, Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil sheila.omedeiros@gmail.com.
authors: Sheila de Oliveira
authors: Sde O
authors: Medeiros
authors: Laboratory of Molecular Virology, Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
authors: Celina Monteiro
authors: CM
authors: Abreu
authors: Laboratory of Molecular Virology, Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
authors: Rodrigo
authors: R
authors: Delvecchio
authors: Fernandes Figueira Institute, FIOCRUZ, Rio de Janeiro, Brazil.
authors: Anísia Praxedes
authors: AP
authors: Ribeiro
authors: Fernandes Figueira Institute, FIOCRUZ, Rio de Janeiro, Brazil.
authors: Zilton
authors: Z
authors: Vasconcelos
authors: Laboratory of Molecular Virology, Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
authors: Rodrigo de Moraes
authors: Rde M
authors: Brindeiro
authors: Laboratory of Molecular Virology, Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
authors: Amilcar
authors: A
authors: Tanuri
mesh_terms: D000818:Animals; D018414:CD8-Positive T-Lymphocytes; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D016181:Feline Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D005500:Follow-Up Studies; D016089:Immunodeficiency Virus, Feline / Q000187:drug effects*; D019259:Lamivudine / Q000627:therapeutic use*; D008969:Molecular Sequence Data; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D019562:Viral Load; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015215:Zidovudine